How many insider trades does FilingIQ track for TRDA?

FilingIQ tracks 405 Form 4 insider transactions for TRDA (Entrada Therapeutics, Inc.), covering filings from Nov 2, 2021 onwards. 26 of those were filed in the last 90 days.

Are TRDA insiders net buyers or net sellers?

Across the full Form 4 history for TRDA, 60 transactions (15%) were open-market purchases and 184 (45%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TRDA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TRDA in?

Entrada Therapeutics, Inc. (TRDA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $452.90M.

TRDA insider trading

NasdaqGM Healthcare

Entrada Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

405

Last 90 days

Buys / sells

15% / 45%

Market cap

$452.90M

About Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Company website: www.entradatx.com

TRDA insider activity at a glance

FilingIQ has scored 405 insider transactions for TRDA since Nov 2, 2021. The most recent filing in our index is dated May 4, 2026.

Across the full history, 60 open-market purchases and 184 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TRDA insider trades is 49.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TRDA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TRDA?: FilingIQ tracks 405 Form 4 insider transactions for TRDA (Entrada Therapeutics, Inc.), covering filings from Nov 2, 2021 onwards. 26 of those were filed in the last 90 days.
Are TRDA insiders net buyers or net sellers?: Across the full Form 4 history for TRDA, 60 transactions (15%) were open-market purchases and 184 (45%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TRDA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TRDA in?: Entrada Therapeutics, Inc. (TRDA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $452.90M.

Methodology & sources

Every TRDA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.